Analysis of thrombomodulin gene polymorphism in women with severe early- onset preeclampsia

Seminars in Thrombosis and Hemostasis

Volumn 25, Issue 5, 1999, Pages 473-479

  Nakabayashi, Masao ^a,d   Yamamoto, Shuji ^b   Suzuki, Koji ^c  

^a TOKYO WOMEN'S MEDICAL UNIVERSITY   (Japan)

^b ASAHI CHEMICAL INDUSTRY CO   (Japan)

^c MIE UNIVERSITY   (Japan)

^d NONE   (Japan)

Author keywords

DNA polymorphism; Dot hybridization; Frequency of allele; Protein C activating cofactor activity; Severe early onset preeclampsia; Thrombomodulin

Indexed keywords

ALANINE; PROTEIN C; THROMBOMODULIN; VALINE;

ADULT; ALLELE; ANIMAL CELL; ARTICLE; CELL STRAIN COS1; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GENETIC POLYMORPHISM; HUMAN; NONHUMAN; POLYMERASE CHAIN REACTION; PREECLAMPSIA; PRIORITY JOURNAL; THROMBOPHILIA;

EID: 0033452690     PISSN: 00946176     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-994953     Document Type: Article

References (24)

1. Esmon NL, Owen WG, Esmon CT. Isolation of a membrane-bound cofactor for thrombin-catalyzed activation of protein C. J Biol Chem 1982;257:859-864
2. Vehar GA, Davie EW. Preparation and properties of bovine factor VIII. Biochemistry 1980;19:401-410
3. Marlar RA, Kleiss AJ, Griffin JH. Mechanism of action of human activated protein C, a thrombin-dependent anticoagulant enzyme. Blood 1982;59:1067-1072
4. Suzuki K, Stenflo J, Dahlbäck B, Teodorsson B. Inactivation of human coagulation factor V by activated protein C. J Biol Chem 1983;258:1914-1920
5. Comp PC, Esmon CT. Generation of fibrinolytic activity by infusion of activated protein C into dogs. J Clin Invest 1981;68: 1221-1228
6. Sakata Y, Curriden S, Lawrence D, Griffin JH, Loskutoff DJ. Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases anti-activator activity. Proc Natl Acad Sci USA 1985;82:1121-1125
7. Esmon CT, Esmon NL, Harris KW. Complex formation between thrombin and thrombomodulin inhibits both thrombin-catalyzed fibrin formation and factor V activation. J Biol Chem 1982;257:7944-7947
8. Suzuki K, Kusuoto H, Hashimoto S. Isolation and characterization of thrombomodulin from bovine lung. Biochim Biophys Acta 1986;882:343-352
9. Salem HH, Maruyama I, Ishii H, Majerus PW. Isolation and characterization of thrombomodulin from human placenta. J Biol Chem 1984;259:12246-12251
10. Kurosawa S, Aoki N. Preparation of thrombomodulin from human placenta. Thromb Res 1985;37:353-364
11. Suzuki K, Kusumoto H, Deyashiki Y, et al. Structure and expression of human thrombomodulin, a thrombin receptor on endothelium acting as a cofactor for protein C activation. EMBO J 1987;6:1891-1897
12. Shirai T, Shiojiri S, Ito H, et al. Gene structure of human thrombomodulin, a cofactor for thrombin-catalyzed activation of protein C. J Biochem 1988;103:281-285
13. Wen D, Dittman WA, Ye RD, Deaven LL, Majerus PW, Sadler JE. Human thrombomodulin: Complete cDNA sequence and chromosome localization of the gene. Biochemistry 1987;26: 4350-4357
14. Jackman RW, Beeler DL, Fritze L, Soff G, Rosenberg RD. Human thrombomodulin gene is intron deleted: Nucleic acid sequences of the cDNA and gene predict protein structure and suggest sites of regulatory control. Proc Natl Acad Sci USA 1987;84:6425-6429
15. Zushi M, Gomi K, Yamamoto S, Maruyama I, Hayashi T, Suzuki K. The last three consecutive epidermal growth factor-like structures of human thrombomodulin comprise the minimum functional domain for protein C-activating cofactor activity and anticoagulant activity. J Biol Chem 1989;264:10351-10353
16. Kurosawa S, Stearns DJ, Jackson KW, Esmon CT. A 10-kDa cyanogen bromide fragment from the epidermal growth factor homology domain of rabbit thrombomodulin contains the primary thrombin binding site. J Biol Chem 1988;263:5993-5996
17. Norlund L, Holm J, Zoller B, Ohlin AK. A common thrombomodulin amino acid dimorphism is associated with myocardial infarction. Thromb Haemost 1997;77:248-251
18. Dekker GA, de Vries JIP, Doelitzsch PM, et al. Underlying disorders associated with severe early-onset preeclampsia. Am J Obstet Gynecol 1995;173:1042-1048
19. Nakabayashi M. The role of coagulation and fibrinolysis system in pathogenesis of toxemia of pregnancy [in Japanese]. Acta Obstet Gynaecol Jpn 1988;40:1000-1009
20. Maniatis T, Fritsch EF, Sambrook J. Molecular Cloning, A Laboratory Manual. Cold Spring Harbor NY: Cold Spring Harbor Laboratory; 1982
21. Sanger F, Nicklen S, Coulson AR. DNA sequencing with chain-terminating inhibitors. Proc Natl Acad Sci USA 1977;74: 5463-5467
22. Mizusawa S, Nishimura S, Seela F. Improvement of the dideoxy chain termination method of DNA sequencing by use of deoxy-7-deazaguanosine triphosphate in place of dGTP. Nucleic Acids Res 1986;14:1319-1324
23. Saiki RK, Scharf S, Faloona F, et al. Enzymatic amplification of β-globin genomic sequences and restriction site analysis for diagnosis of sickle cell anemia. Science 1985;230: 1350-1354
24. Suzuki K, Hayashi T, Nishioka J, et al. A domain of epidermal growth factor-like structures of human thrombomodulin is essential for thrombin binding and for protein C activation. J Biol Chem 1989;264:4872-4876